ALK Rearrangement-Positive Pancreatic Cancer with Brain Metastasis Has Remarkable Response to ALK Inhibitors: A Case Report

被引：11
|
作者：
Ou, Kai [1 ]
Liu, Xiu [1 ]
Li, Weihua [2 ]
Yang, Yi [3 ]
Ying, Jianming [2 ,4 ]
Yang, Lin [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Pathol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Intervent Therapy, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Key Lab Gene Editing Screening & Res & Dev R&D Di, Beijing, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词：
pancreatic cancer; brain metastases; ALK Kinase; EML4-ALK fusion protein; crizotinib; alectinib; CSF CONCENTRATION; IDENTIFICATION; FUSION; CRIZOTINIB; CHEMOTHERAPY; EXPRESSION; CARCINOMA; SURVIVAL; TUMORS; GENE;
D O I：
10.3389/fonc.2021.724815
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Patients with metastatic pancreatic cancer typically have poor prognosis due to the limited effectiveness of existing treatment options. ALK rearrangement-positive is rare in pancreatic cancer, but may occur in those with KRAS-wild type. We present a 34-year-old young man with ALK rearrangement-positive and KRAS-wild pancreatic cancer who had a remarkable response to crizotinib after resistance to prior chemotherapy and re-response to alectinib after brain metastases developed. This clinical observation suggests that comprehensive molecular profiling to guide targeted therapies is not only feasible, but also significantly improves survival outcomes for a subgroup of patients with pancreatic cancer.
引用
收藏
页数：8
相关论文
共 50 条
  • [1] RET rearrangement-positive pancreatic cancer has remarkable response to pralsetinib: a case report
    Zhang, Tongyi
    Wang, Hongwei
    Cai, Zhiwei
    Zhang, Siqi
    Jiang, Chongyi
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [2] Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer
    Iwama, Eiji
    Okamoto, Isamu
    Harada, Taishi
    Takayama, Koichi
    Nakanishi, Yoichi
    [J]. ONCOTARGETS AND THERAPY, 2014, 7 : 375 - 385
  • [3] Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement-Positive Non-Small-Cell Lung Cancer
    Kaneda, Hiroyasu
    Okamoto, Isamu
    Nakagawa, Kazuhiko
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (04) : E32 - E33
  • [4] AlectinibTransformation of ALK rearrangement-positive adenocarcinoma to small-cell lung cancer in association with acquired resistance to alectinib : case report
    [J]. Reactions Weekly, 2016, 1607 (1) : 35 - 35
  • [5] Anaplastic Lymphoma Kinase (ALK) Rearrangement-positive Lung Cancer with Transformation to Pleomorphic Carcinoma
    Kamide, Yosuke
    Kaira, Kyoichi
    Watanabe, Takuya
    Kuribayashi, Shiko
    Ozawa, Atsushi
    Koga, Yasuhiko
    Ono, Akihiro
    Sunaga, Noriaki
    Hisada, Takeshi
    Oyama, Tetsunari
    Yamada, Masanobu
    [J]. INTERNAL MEDICINE, 2015, 54 (22) : 2905 - 2909
  • [6] Crizotinib for ALK rearrangement-positive non-small cell lung cancer patients with central nervous system metastasis
    Takeda, Masayuki
    Nakagawa, Kazuhiko
    [J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S554 - S556
  • [7] THE CASE REPORT OF LUNG ADENOCARCINOMA THYROID METASTASIS OF ALK REARRANGEMENT
    Tian, Tian
    Hong, Fu
    Zhang, Zhihong
    Qian, Liting
    [J]. ACTA MEDICA MEDITERRANEA, 2020, 36 (03): : 1307 - 1310
  • [8] Primary Resistance to ALK Inhibitors in a Patient with Nonsmall Cell Lung Cancer with ALK Rearrangement: A Case Report with Review of Literature
    Devaraj, Suma
    Panda, Soumya Surath
    Arun, Gourab
    Panda, Adya Kinkar
    Mohapatra, Debahuti
    Moharana, Lalatendu
    Kolluri, Spoorthy
    Kilaru, Sindhu
    Mohanty, Swati Sucharita
    Biswas, Ghanashyam
    [J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2023,
  • [9] Omental Metastasis from ALK-positive Lung Cancer — A Case Report
    Taha Khalid
    Brendan Phelan
    Ala Yousif
    [J]. The Egyptian Journal of Internal Medicine, 2020, 32 (1)
  • [10] Case Report: A Pregnant Woman Diagnosed as ALK-Rearrangement Lung Large Cell Neuroendocrine Cancer With Brain Metastasis
    Fu, Zaixiang
    Zhu, Ganggui
    Wang, Liquan
    Hu, Shen
    Cheng, Lu
    Liu, Fuyi
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
12345